Publications by authors named "Gaurav Pathria"

Claim this Profile
A
Ancestry-associated co-alteration landscape of KRAS and EGFR-altered non-squamous NSCLC.
Saumya D Sisoudiya, Armande Ang Houle, Tharu Fernando, Timothy R Wilson, Jennifer L Schutzman, Gaurav Pathria

NPJ Precis Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment.
Nicole M Sodir, Gaurav Pathria, Joanne I Adamkewicz, Elizabeth H Kelley, Jawahar Sudhamsu

Cancer Discov· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NRF2 mediates melanoma addiction to GCDH by modulating apoptotic signalling.
Sachin Verma, David Crawford, Ali Khateb, Yongmei Feng, Eduard Sergienko, Gaurav Pathria

Nat Cell Biol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and Characterization of IMD-0354 as a Glutamine Carrier Protein Inhibitor in Melanoma.
Yongmei Feng, Gaurav Pathria, Susanne Heynen-Genel, Michael Jackson, Brian James

Mol Cancer Ther· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MAPK signaling regulates c-MYC for melanoma cell adaptation to asparagine restriction.
Gaurav Pathria, Sachin Verma, Jun Yin, David A Scott, Ze'ev A Ronai

EMBO Rep· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing the Co-vulnerabilities of Amino Acid-Restricted Cancers.
Gaurav Pathria, Ze'ev A Ronai

Cell Metab· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translational reprogramming marks adaptation to asparagine restriction in cancer.
Gaurav Pathria, Joo Sang Lee, Erez Hasnis, Kristofferson Tandoc, David A Scott

Nat Cell Biol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting the Warburg effect via LDHA inhibition engages ATF4 signaling for cancer cell survival.
Gaurav Pathria, David A Scott, Yongmei Feng, Joo Sang Lee, Yu Fujita

EMBO J· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRN 2 Invade.
Gaurav Pathria, Ze'ev A Ronai

Cancer Cell· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Signal Sequence Receptor 2 is required for survival of human melanoma cells as part of an unfolded protein response to endoplasmic reticulum stress.
Bhavuk Garg, Gaurav Pathria, Christine Wagner, Margarita Maurer, Stephan N Wagner

Mutagenesis· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RanBP3 Regulates Melanoma Cell Proliferation via Selective Control of Nuclear Export.
Gaurav Pathria, Bhavuk Garg, Christine Wagner, Kanika Garg, Melanie Gschaider

J Invest Dermatol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NVP-LDE225, a potent and selective SMOOTHENED antagonist reduces melanoma growth in vitro and in vivo.
Ahmad Jalili, Kirsten D Mertz, Julia Romanov, Christine Wagner, Frank Kalthoff, Gaurav Pathria

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MTSS1 is a metastasis driver in a subset of human melanomas.
Kirsten D Mertz, Gaurav Pathria, Christine Wagner, Juha Saarikangas, Andrea Sboner

Nat Commun· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of CRM1-mediated nucleocytoplasmic transport: triggering human melanoma cell apoptosis by perturbing multiple cellular pathways.
Gaurav Pathria, Christine Wagner, Stephan N Wagner

J Invest Dermatol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual suppression of the cyclin-dependent kinase inhibitors CDKN2C and CDKN1A in human melanoma.
Ahmad Jalili, Christine Wagner, Mikhail Pashenkov, Gaurav Pathria, Kirsten D Mertz

J Natl Cancer Inst· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polo-like kinase 1 is a potential therapeutic target in human melanoma.
Ahmad Jalili, Anna Moser, Mikhail Pashenkov, Christine Wagner, Gaurav Pathria

J Invest Dermatol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of enzyme-linked immunosorbent assay test with immunoblot assay in the diagnosis of pemphigus in Indian patients.
Sujay Khandpur, Vinod K Sharma, Alpana Sharma, Gaurav Pathria, Abhigyan Satyam

Indian J Dermatol Venereol Leprol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis